Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet 2800 Kgs, Lyngby, Denmark.
GeneMill, Shared Research Facilities, Faculty of Health and Life Sciences, University of Liverpool, Crown St, Liverpool, L69 7ZB, UK.
Metab Eng. 2022 Jul;72:376-390. doi: 10.1016/j.ymben.2022.05.004. Epub 2022 May 20.
Membrane transport proteins are potential targets for medical and biotechnological applications. However, more than 30% of reported membrane transporter families are either poorly characterized or lack adequate functional annotation. Here, adaptive laboratory evolution was leveraged to identify membrane transporters for a set of four amino acids as well as specific mutations that modulate the activities of these transporters. Specifically, Escherichia coli was adaptively evolved under increasing concentrations of L-histidine, L-phenylalanine, L-threonine, and L-methionine separately with multiple replicate evolutions. Evolved populations and isolated clones displayed growth rates comparable to the unstressed ancestral strain at elevated concentrations (four-to six-fold increases) of the targeted amino acids. Whole genome sequencing of the evolved strains revealed a diverse number of key mutations, including SNPs, small deletions, and copy number variants targeting the transporters leuE for histidine, yddG for phenylalanine, yedA for methionine, and brnQ and rhtC for threonine. Reverse engineering of the mutations in the ancestral strain established mutation causality of the specific mutations for the tolerant phenotypes. The functional roles of yedA and brnQ in the transport of methionine and threonine, respectively, are novel assignments and their functional roles were validated using a flow cytometry cellular accumulation assay. To demonstrate how the identified transporters can be leveraged for production, an L-phenylalanine overproduction strain was shown to be a superior producer when the identified yddG exporter was overexpressed. Overall, the results revealed the striking efficiency of laboratory evolution to identify transporters and specific mutational mechanisms to modulate their activities, thereby demonstrating promising applicability in transporter discovery efforts and strain engineering.
膜转运蛋白是医学和生物技术应用的潜在靶点。然而,超过 30%的报道的膜转运蛋白家族要么特征描述不佳,要么缺乏足够的功能注释。在这里,适应性实验室进化被用来鉴定一组四种氨基酸的膜转运蛋白,以及调节这些转运蛋白活性的特定突变。具体来说,大肠杆菌分别在增加的 L-组氨酸、L-苯丙氨酸、L-苏氨酸和 L-蛋氨酸浓度下进行适应性进化,进行了多次重复进化。进化后的种群和分离的克隆在目标氨基酸浓度升高(四到六倍)时,表现出与未受压力的祖先菌株相当的生长速度。进化菌株的全基因组测序揭示了大量关键突变,包括 SNP、小缺失和针对转运蛋白 leuE 的组氨酸、yddG 的苯丙氨酸、yedA 的蛋氨酸以及 brnQ 和 rhtC 的苏氨酸的拷贝数变异。在祖先菌株中反向工程这些突变,确定了特定突变对耐受表型的因果关系。yedA 和 brnQ 分别在蛋氨酸和苏氨酸转运中的功能作用是新的分配,并且使用流式细胞术细胞积累测定法验证了它们的功能作用。为了展示鉴定出的转运蛋白如何用于生产,当鉴定出的 yddG 外排泵过表达时,L-苯丙氨酸过生产菌株被证明是一种更好的生产菌株。总的来说,这些结果表明实验室进化在鉴定转运蛋白和调节其活性的特定突变机制方面具有惊人的效率,从而在转运蛋白发现工作和菌株工程方面展示了有前景的应用。